查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2087609

經導管肺動脈瓣膜市場：依產品類型、瓣膜材質、輸送系統、疾病類型、技術整合和最終用戶分類－2026-2032年全球市場預測

Transcatheter Pulmonary Valve Market by Product Type, Valve Material, Delivery System, Disease Type, Technology Integration, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，經導管肺動脈瓣膜市場將成長至 1.3315 億美元，複合年成長率為 5.29%。

主要市場統計數據
基準年 2025 9281萬美元
預計年份：2026年 9755萬美元
預測年份 2032 1.3315億美元
複合年成長率 (%) 5.29%

經導管肺動脈瓣膜市場簡介

經導管肺動脈瓣置換術術是一種專門用於治療右心室流出道功能障礙的結構性心臟介入手術，主要適用於接受過先天性心臟疾病修復手術的患者，例如法洛氏四合症、肺動脈閉鎖或有導管修復史的患者。經導管肺動脈瓣置換術無需再次開胸手術即可恢復肺動脈瓣功能，從而支持終身治療方案，該方案適用於許多患者在從兒童到青少年期再到成年期的各個治療階段，需要多次再次介入治療的情況。

經導管肺動脈瓣治療領域的變革性變化

經導管肺動脈瓣治療的趨勢正從單獨使用導管治療轉向更廣泛的解剖結構，包括先天性和外科修復後的右心室流出道畸形。這種轉變具有重要的臨床意義，因為許多法洛氏四合症修復術後患者的右心室流出道擴大且呈非圓柱形，這在以前限制了經導管治療的適應症，並增加了對肺動脈瓣再次手術的依賴。

人工智慧（AI）對TPV治療的累積影響

人工智慧 (AI) 正透過自動化影像診斷、解剖結構分類、輔助選擇器材尺寸以及術後後續觀察方式，逐步影響經導管肺動脈瓣膜治療。 AI 驅動的 CT 和心臟 MRI 分割技術有助於量化右心室容積、肺動脈瓣逆流程度、導管尺寸、鈣化、著陸區形狀以及與冠狀動脈的空間關係。這些變數直接影響手術的可行性和病人的選擇。

關於經導管肺動脈瓣膜治療引入的關鍵區域見解。

由於核准已通過核准的普及、成熟的成人先天性心臟疾病診療計畫、完善的結構性心臟疾病醫療體係以及先進影像技術的廣泛應用，北美仍然是經導管肺動脈瓣膜治療的領先地區。美國透過其專門治療先天性和結構性心臟病的醫療中心，引領該地區大部分的治療活動。同時，加拿大則憑藉著統一的先天性心臟疾病心臟疾病、省級診療路徑以及支持患者在指定轉診醫院就診的公共部門報銷機制，在先天性心臟疾病治療領域佔據領先地位。

針對七國集團、歐盟、金磚國家、東協、海灣合作理事會和北約的關鍵群體特定見解。

在經濟和政治集團中，七國集團（G7）對經導管肺動脈瓣膜的需求基礎最為成熟，這得益於其在先天性心臟疾病治療方面的先進技術、完善的醫保報銷體系、強大的影像基礎設施、專業的導管介入檢查室以及對已通過核准技術的早期應用。北約成員國與北美和歐洲的許多高所得市場重疊，這加強了臨床合作、採購穩定性、醫生交流以及標準化的心血管護理實踐，從而為經導管肺動脈瓣膜的日益普及創造了關鍵環境。

經導管肺動脈瓣膜擴張的關鍵國家洞察

美國是經導管肺動脈瓣膜置換術推廣領域最具影響力的國家，這得益於其完善的法規核准體系、兒童和成人先天性心臟疾病計畫、先進的影像技術以及健全的結構性心臟疾病診療體系。加拿大則透過省級合作和集中設立的先天性心臟疾病中心緊隨其後。在墨西哥和巴西，對微創先天性心臟疾病再治療的需求日益成長，但其可及性仍然很大程度上取決於醫院預算、私人保險覆蓋範圍、公共採購週期以及訓練有素的介入性心臟病專家的集中程度。

為經導管肺動脈瓣治療領域的領導者提供的實用建議

行業領導企業應優先考慮廣泛的解剖學適用性、瓣膜的耐用性和易於植入性。能夠適應寬闊的右心室流出道、減少瓣週漏、最大限度降低支架破裂風險、支持精確定位並確保未來再次干預選擇的產品，最能滿足經導管肺動脈瓣置換術中最關鍵的臨床需求。

TPV市場分析的調查方法

本執行摘要基於對二手研究、臨床文獻綜述、監管資訊、醫療設備核准情況、先天性心臟疾病指南、醫院容量、影像技術應用以及區域報銷趨勢的橫斷面市場三角分析。所考慮的資訊來源包括同行評審的循環系統期刊、公開的監管信息、專業學會指南、臨床試驗記錄、醫院容量指標以及公開的醫療技術資訊披露，且不依賴於推測性的市場規模估計或預測。

結論：經導管肺動脈瓣膜市場展望

經導管肺動脈瓣膜市場正從針對特定先天性疾病的介入治療，發展成為結構性心臟疾病終身管理的更廣泛領域。這一成長得益於成人先天性心臟疾病患者數量的增加、心臟磁振造影（MRI）和電腦斷層掃描（CT）技術提高治療計劃的精確度、解剖適應症的擴大、瓣中瓣手術經驗的積累，以及在臨床適宜的情況下，人們越來越傾向於選擇微創的再次介入治療。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 經導管肺動脈瓣膜市場：依產品類型分類

  • 球囊擴張型閥
  • 自膨脹閥
  • 先進的閥門系統

第8章 經導管肺動脈瓣膜市場：依瓣膜材質分類

  • 生物瓣膜（組織瓣膜）
  • 合成/聚合物閥門

第9章 經導管肺動脈瓣膜市場：依輸送系統分類

  • 經靜脈入路
  • 經頸靜脈入路
  • 混合式外科手術和經導管治療

第10章 經導管肺動脈瓣膜市場：依疾病類型分類

  • 肺動脈瓣狹窄
  • 肺動脈瓣逆流
  • 右心室流出道（RVOT）功能障礙
  • 先天性心臟疾病

第11章 經導管肺動脈瓣膜市場：依技術整合分類

  • 影像引導系統
  • 人工智慧與導航的融合

第12章 經導管肺動脈瓣膜市場：依最終用戶分類

  • 醫院
  • 門診手術中心
  • 專業心臟病中心

第13章 經導管肺動脈瓣膜市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 經導管肺動脈瓣膜市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 經導管肺動脈瓣膜市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Abbott Laboratories
  • Artivion Inc.
  • Boston Scientific Corporation
  • Braile Biomedica
  • Edwards Lifesciences Corporation
  • Lepu Medical Technology
  • LivaNova PLC
  • Med-Zenith
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • OrbusNeich Medical Group
  • PolyVascular Inc.
  • Taewoong Medical
  • Terumo Corporation
  • Venus Medtech（Hangzhou）Inc.
  • Xeltis AG
Product Code: MRR-03168519576D

The Transcatheter Pulmonary Valve Market is projected to grow by USD 133.15 million at a CAGR of 5.29% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 92.81 million
Estimated Year [2026] USD 97.55 million
Forecast Year [2032] USD 133.15 million
CAGR (%) 5.29%

Transcatheter Pulmonary Valve Market Introduction

Transcatheter pulmonary valve replacement is a specialized structural heart intervention used to treat right ventricular outflow tract dysfunction, most often in patients with repaired congenital heart disease, including tetralogy of Fallot, pulmonary atresia, or prior conduit repair. By restoring pulmonary valve competence without repeat open-heart surgery, transcatheter pulmonary valve technologies support a lifelong care pathway in which many patients require multiple reinterventions across pediatric, adolescent, and adult stages of care.

The market is supported by a clinically established evidence base, including long-term follow-up for early transcatheter pulmonary valve systems and expanding use of balloon-expandable and self-expanding platforms for selected anatomies. Demand is closely tied to congenital heart disease surveillance, cardiac MRI and CT-based sizing, pediatric-to-adult transition programs, multidisciplinary heart teams, and the availability of experienced congenital interventional cardiology centers.

Transformative Shifts in the Transcatheter Pulmonary Valve Landscape

The transcatheter pulmonary valve landscape is shifting from conduit-only treatment toward broader anatomical coverage, including native and surgically repaired right ventricular outflow tracts. This change is clinically significant because many repaired tetralogy of Fallot patients have enlarged, non-cylindrical outflow tracts that historically limited transcatheter eligibility and increased reliance on repeat surgical pulmonary valve replacement.

Clinical practice is also moving toward lifetime valve management rather than single-episode intervention. Operators increasingly consider staged prestenting, valve-in-valve planning, coronary compression testing, endocarditis risk mitigation, radiation reduction, and future reaccess when selecting a device. As adult congenital heart disease populations grow due to improved survival, hospitals with combined pediatric and adult structural heart capabilities are better positioned to manage referrals, imaging, intervention, and long-term surveillance.

Cumulative Impact of Artificial Intelligence on TPV Care

Artificial intelligence is beginning to influence transcatheter pulmonary valve care through imaging automation, anatomy classification, device sizing support, and post-procedure surveillance. AI-enabled segmentation of CT and cardiac MRI can help quantify right ventricular volumes, pulmonary regurgitation severity, conduit dimensions, calcification, landing-zone geometry, and spatial relationships with the coronary arteries, which are variables that directly shape procedural feasibility and patient selection.

The near-term impact is expected to be cumulative rather than disruptive. AI tools can reduce planning time, improve measurement reproducibility, support longitudinal monitoring, and help standardize multidisciplinary review, but clinical decisions still require physician oversight, validated algorithms, transparent performance data, and regulatory clearance where applicable. The strongest commercial value will come from integrating AI into workflow platforms that connect congenital cardiology, radiology, catheterization laboratories, surgical teams, and longitudinal follow-up programs.

Key Regional Insights for Transcatheter Pulmonary Valve Adoption

North America remains a leading region for transcatheter pulmonary valve adoption due to cleared device availability, mature adult congenital heart disease programs, established structural heart infrastructure, and high utilization of advanced imaging. The United States drives most regional procedure activity through specialized congenital and structural heart centers, while Canada benefits from centralized congenital cardiac networks, provincial care pathways, and public-sector reimbursement mechanisms that support access in selected referral hospitals.

Europe shows broad clinical expertise across the United Kingdom, Germany, France, Italy, and Spain, supported by congenital heart disease guidelines, national referral networks, and experienced tertiary centers. The European regulatory environment has increased evidence, clinical evaluation, and post-market surveillance expectations for medical devices, which can lengthen commercialization timelines but strengthens quality, traceability, and safety standards for transcatheter pulmonary valve technologies.

Asia-Pacific is expanding as China, India, Japan, South Korea, and Australia invest in congenital heart services, cardiac imaging, and structural heart capabilities. Latin America, led by Brazil and Mexico, is growing selectively through private hospitals, academic centers, and national reference institutions. The Middle East, particularly high-income Gulf states, is building high-acuity cardiac programs and cross-border referral capacity, while Africa remains constrained by limited congenital catheterization infrastructure, workforce shortages, and delayed diagnosis, despite clear long-term clinical need for less invasive pulmonary valve reintervention.

Key Group Insights Across G7, EU, BRICS, ASEAN, GCC, and NATO

Among economic and political groups, the G7 represents the most mature base for transcatheter pulmonary valve demand because it combines advanced congenital care, established reimbursement frameworks, strong imaging infrastructure, specialized catheterization laboratories, and earlier access to approved technologies. NATO membership overlaps with many high-income markets in North America and Europe, reinforcing clinical collaboration, procurement stability, physician exchange, and standardized cardiovascular care practices across several leading transcatheter pulmonary valve adoption environments.

The European Union is strategically important because harmonized regulatory oversight shapes evidence expectations for manufacturers seeking broader European access and emphasizes post-market clinical follow-up, device traceability, and safety monitoring. BRICS countries offer scale, especially through China, India, and Brazil, but access varies by reimbursement coverage, specialist availability, domestic procurement priorities, and import pathways. ASEAN markets are earlier in adoption, with more developed cardiac programs in countries such as Singapore, Thailand, and Malaysia serving as regional reference points. GCC countries are investing in tertiary cardiovascular centers, medical tourism, and high-acuity care capacity, creating opportunities for premium structural heart technologies when clinical training, reimbursement alignment, and referral networks are in place.

Key Country Insights for Transcatheter Pulmonary Valve Growth

The United States is the most influential country environment for transcatheter pulmonary valve adoption, supported by regulatory clearances, pediatric and adult congenital heart programs, advanced imaging capacity, and strong structural heart ecosystems. Canada follows through coordinated provincial systems and specialized congenital centers that concentrate expertise. Mexico and Brazil show rising demand for less invasive congenital heart reintervention, but access remains more dependent on hospital budgets, private insurance coverage, public procurement cycles, and the concentration of trained interventional cardiologists.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine guideline-driven congenital heart care with leading tertiary centers and established multidisciplinary decision-making. Germany is particularly relevant for procedural capacity, health technology evaluation, and advanced hospital infrastructure, while the United Kingdom and France benefit from organized specialist networks. Italy and Spain maintain strong congenital cardiology expertise, although regional reimbursement and hospital access may influence adoption pace. Russia has meaningful clinical need but faces variability in access linked to procurement complexity, referral geography, and geopolitical constraints affecting device availability.

China and India are high-potential markets due to large congenital heart disease populations, improving diagnosis, and expanding tertiary cardiac care, but adoption depends on affordability, reimbursement development, approved device access, and trained operators. Japan, South Korea, and Australia have advanced imaging, rigorous clinical standards, and tertiary cardiac care systems that support quality-driven uptake where approved devices and reimbursement pathways are available. Across these countries, durable outcomes, anatomical fit, operator training, and long-term surveillance remain central to adoption.

Actionable Recommendations for Transcatheter Pulmonary Valve Leaders

Industry leaders should prioritize anatomical breadth, durable valve performance, and ease of implantation. Products that address large native right ventricular outflow tracts, reduce paravalvular leak, minimize stent fracture risk, support accurate positioning, and preserve future intervention options are positioned to meet the most important clinical needs in transcatheter pulmonary valve replacement.

Commercial strategy should focus on centers of excellence, congenital heart disease registries, physician education, proctoring, imaging-based planning, and evidence generation in real-world cohorts. Manufacturers and technology developers should invest in AI-enabled imaging partnerships, procedural simulation, operator training, patient follow-up systems, and post-market surveillance while aligning market access strategies with local reimbursement, regulatory, and health technology assessment requirements.

Research Methodology for TPV Market Intelligence

This executive summary is based on secondary research, clinical literature review, regulatory intelligence, and market triangulation across device approvals, congenital heart disease guidelines, hospital capabilities, imaging adoption, and regional reimbursement dynamics. Sources considered include peer-reviewed cardiology publications, public regulatory information, professional society guidance, clinical trial records, hospital capability indicators, and publicly available medical technology disclosures without relying on speculative sizing or forecasting.

Insights were validated through cross-comparison of clinical adoption drivers, procedure eligibility criteria, anatomical requirements, regional infrastructure, access conditions, and competitive technology trends. The methodology emphasizes verified evidence over market estimation and highlights practical indicators such as approved indications, long-term safety evidence, specialist availability, imaging infrastructure, reimbursement readiness, and post-market surveillance obligations.

Conclusion: Outlook for the Transcatheter Pulmonary Valve Market

The transcatheter pulmonary valve market is advancing from a niche congenital intervention toward a broader lifetime management segment within structural heart care. Adoption is supported by expanding adult congenital heart disease populations, improved cardiac MRI and CT planning, wider anatomical eligibility, growing valve-in-valve experience, and increasing preference for less invasive reintervention when clinically appropriate.

Sustainable leadership will depend on clinical evidence, device versatility, operator training, regional access planning, and digital workflow integration. Stakeholders that combine robust valve platforms with imaging intelligence, registry participation, post-market data, and multidisciplinary care support will be best positioned to create value in this specialized and strategically important cardiovascular field.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Transcatheter Pulmonary Valve Market, by Product Type

  • 7.1. Balloon-Expandable Valves
  • 7.2. Self-Expanding Valves
  • 7.3. Advanced Valve Systems

8. Transcatheter Pulmonary Valve Market, by Valve Material

  • 8.1. Biological (Tissue) Valve
  • 8.2. Synthetic / Polymer Valves

9. Transcatheter Pulmonary Valve Market, by Delivery System

  • 9.1. Transvenous Approach
  • 9.2. Transjugular Approach
  • 9.3. Hybrid Surgical-Transcatheter Approach

10. Transcatheter Pulmonary Valve Market, by Disease Type

  • 10.1. Pulmonary Valve Stenosis
  • 10.2. Pulmonary Valve Regurgitation
  • 10.3. Right Ventricular Outflow Tract (RVOT) Dysfunction
  • 10.4. Congenital Heart Diseases

11. Transcatheter Pulmonary Valve Market, by Technology Integration

  • 11.1. Imaging-Guided Systems
  • 11.2. AI & Navigation Integration

12. Transcatheter Pulmonary Valve Market, by End User

  • 12.1. Hospitals
  • 12.2. Ambulatory Surgical Centers
  • 12.3. Specialty Cardiac Centers

13. Transcatheter Pulmonary Valve Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Transcatheter Pulmonary Valve Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Transcatheter Pulmonary Valve Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Abbott Laboratories
  • 17.2. Artivion Inc.
  • 17.3. Boston Scientific Corporation
  • 17.4. Braile Biomedica
  • 17.5. Edwards Lifesciences Corporation
  • 17.6. Lepu Medical Technology
  • 17.7. LivaNova PLC
  • 17.8. Med-Zenith
  • 17.9. Medtronic plc
  • 17.10. Meril Life Sciences Pvt. Ltd.
  • 17.11. MicroPort Scientific Corporation
  • 17.12. OrbusNeich Medical Group
  • 17.13. PolyVascular Inc.
  • 17.14. Taewoong Medical
  • 17.15. Terumo Corporation
  • 17.16. Venus Medtech (Hangzhou) Inc.
  • 17.17. Xeltis AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BALLOON-EXPANDABLE VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BALLOON-EXPANDABLE VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BALLOON-EXPANDABLE VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SELF-EXPANDING VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SELF-EXPANDING VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SELF-EXPANDING VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ADVANCED VALVE SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ADVANCED VALVE SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ADVANCED VALVE SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOLOGICAL (TISSUE) VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIOLOGICAL (TISSUE) VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOLOGICAL (TISSUE) VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SYNTHETIC / POLYMER VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SYNTHETIC / POLYMER VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SYNTHETIC / POLYMER VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL TRANSVENOUS APPROACH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL TRANSVENOUS APPROACH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL TRANSVENOUS APPROACH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL TRANSJUGULAR APPROACH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL TRANSJUGULAR APPROACH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL TRANSJUGULAR APPROACH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HYBRID SURGICAL-TRANSCATHETER APPROACH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HYBRID SURGICAL-TRANSCATHETER APPROACH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HYBRID SURGICAL-TRANSCATHETER APPROACH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PULMONARY VALVE STENOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PULMONARY VALVE STENOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PULMONARY VALVE STENOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PULMONARY VALVE REGURGITATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PULMONARY VALVE REGURGITATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PULMONARY VALVE REGURGITATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RIGHT VENTRICULAR OUTFLOW TRACT (RVOT) DYSFUNCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RIGHT VENTRICULAR OUTFLOW TRACT (RVOT) DYSFUNCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RIGHT VENTRICULAR OUTFLOW TRACT (RVOT) DYSFUNCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CONGENITAL HEART DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CONGENITAL HEART DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CONGENITAL HEART DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL IMAGING-GUIDED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL IMAGING-GUIDED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL IMAGING-GUIDED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AI & NAVIGATION INTEGRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AI & NAVIGATION INTEGRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AI & NAVIGATION INTEGRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SPECIALTY CARDIAC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SPECIALTY CARDIAC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SPECIALTY CARDIAC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. GCC TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 111. GCC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. GCC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 113. GCC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 114. GCC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. GCC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 116. GCC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. G7 TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 132. G7 TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. G7 TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 134. G7 TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 135. G7 TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. G7 TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 137. G7 TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. NATO TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 139. NATO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. NATO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. NATO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 142. NATO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. NATO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 144. NATO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 154. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 156. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 157. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 159. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. MEXICO TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. MEXICO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. MEXICO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 163. MEXICO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 164. MEXICO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. MEXICO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 166. MEXICO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. BRAZIL TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. BRAZIL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. BRAZIL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 170. BRAZIL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 171. BRAZIL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. BRAZIL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 173. BRAZIL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED KINGDOM TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED KINGDOM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED KINGDOM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED KINGDOM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED KINGDOM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED KINGDOM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED KINGDOM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 184. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 185. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 187. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 191. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 192. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 194. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. RUSSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. RUSSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. RUSSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 198. RUSSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 199. RUSSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. RUSSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 201. RUSSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 205. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 206. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 208. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 210. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 212. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 213. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 215. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 226. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 227. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 229. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 231. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 233. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 234. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 236. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. AUSTRALIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 238. AUSTRALIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. AUSTRALIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 240. AUSTRALIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 241. AUSTRALIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. AUSTRALIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 243. AUSTRALIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 247. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 248. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
  • TABLE 250. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)